Literature DB >> 6834903

Economic costs of schizophrenia: a postdischarge study.

C F Muller, C L Caton.   

Abstract

Measurement of the costs of health care and work loss of chronic mental patients is a vital link between clinical care and political decisions. If costs associated with poor outcomes of deinstitutionalized patients are identified, the margin for investing in programs that could improve outcomes without raising overall costs is also identified. This study analyzed direct and indirect costs in the first year after 119 chronic schizophrenics, drawn from public and voluntary hospitals serving Manhattan's upper West Side, were discharged from the hospital. The main elements in direct costs were community aftercare, rehospitalizations, and general medical care. Wage loss was used as the measure of indirect costs and was based on comparison with national figures for similar age/sex/ethnic groups. The risk of rehospitalization is the principal factor affecting direct costs. Wage loss because of unemployment was substantial. Because use of vocational rehabilitation services was low, these findings suggest the importance of developing employment opportunities and appropriate work environments.

Entities:  

Mesh:

Year:  1983        PMID: 6834903     DOI: 10.1097/00005650-198301000-00007

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  3 in total

Review 1.  Mental health care costs: paucity of measurement.

Authors:  P McCrone; S Weich
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1996-03       Impact factor: 4.328

2.  Direct costs of schizophrenia in Italian community psychiatric services.

Authors:  L Garattini; C Rossi; F Tediosi; C Cornaggia; G Covelli; C Barbui; F Parazzini
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

3.  [Costs of psychiatric treatment: a comparative approach to 3 categories of patients].

Authors:  W Fischer; L Barrelet
Journal:  Soz Praventivmed       Date:  1987
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.